Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. The move, effective ...

CVS Health appointed David Joyner president and CEO, effective Oct. 17, replacing Karen Lynch, who stepped down from the position. Mr. Joyner most recently served as executive vice president of ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

R.I. — CVS Health will exit its core infusion services business in the coming months and plans to either close or sell 29 related pharmacies. The company stopped taking new patients seeking ...

CVS Health CVS-2.08%decrease; red down pointing triangle is naming longtime executive David Joyner as its new chief, succeeding Karen Lynch at the helm of the struggling healthcare giant.

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

CVS Health has replaced Karen Lynch with David Joyner as CEO, it said Friday, part of an attempt to turn the struggling company around. Joyner was previously the president of CVS Caremark, ...

CVS Health shares fell below $58 during premarket trading on Friday, on track for the pharmacy chain’s worst loss since a 12% dip on March 15, 2020. The company said in a statement Friday that ...